Implementation of Finnish Prehospital Stroke Scale to Emergency Medical Services
1 other identifier
observational
200
1 country
1
Brief Summary
The investigators have developed a simple prehospital stroke scale (FPSS), containing 5 dichotomized items to recognize both large and small artery thrombi of the brain. FPSS is implemented to both emergency medical services and later, to emergency response centers. The efficacy of the scale and possible improvement of both the patient flow and treatment results will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 24, 2018
CompletedFirst Submitted
Initial submission to the registry
April 25, 2018
CompletedFirst Posted
Study publicly available on registry
May 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFebruary 7, 2020
February 1, 2020
3.7 years
April 25, 2018
February 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy
Accuracy of Finnish Prehospital Stroke Scale used in prehospital settingto detect a large vessel occlusion Finnish Prehospital Stroke Scale (FPSS) includes the following items: Facial droop 0-1, Weakness of one or more extremities 0-1, Difficulty of understand or produce speech, including slurring 0-1, Field cut of visus or blindness 0-1, Partial or fixed gaze or head deviation away from the paretic side 0 or 4. Total points 1-4 predicts non-LVO, ≥ 5 predicts LVO 0-8 (non-LVO= small or medium-sized vessel occlusion; iv-thrombolysis candidate; LVO= large vessel occlusion; endovascular treatment candidate)
3 years
Secondary Outcomes (3)
90 day survival
3 years
90 day modified Rankin score
3 years
Onset to treatment time
3 years
Eligibility Criteria
All patients with acute stroke in a population of 1 million
You may qualify if:
- Acute ischaemic stroke
- Prehospital susipicion of large vessel occlusion
You may not qualify if:
- \- Stroke mimic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tampere University Hospitallead
- Central Finland Hospital Districtcollaborator
- Vaasa Central Hospital, Vaasa, Finlandcollaborator
- Seinajoki Central Hospitalcollaborator
- Satakunta Central Hospitalcollaborator
- PaijatHame Central Hospitalcollaborator
Study Sites (1)
Tampere University Hospital
Tampere, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2018
First Posted
May 9, 2018
Study Start
April 24, 2018
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
February 7, 2020
Record last verified: 2020-02